Breaking News, Financial News

2Q Financial Report: Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 2Q Revenues: $189.9 million (+3%) 2Q Earnings: $3 million (-21%) YTD Revenues: $347.8 million (+3%) YTD Loss: $8.5 million (earnings were $9.8 million YTD2005) Comments: Ebitda revenues were flat at $24.2 million for the quarter. YTD revenues were $38.2 million, down 17%. This decline was primarily due to lower revenues from a generic product, where the company’s client lost a major customer, and additional costs incurred as part of the corrective action plan to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters